TargImmune Therapeutics AG

The TargImmune team are dedicated to transforming lives by bringing our first-in-class cancer-fighting Ta:RNATM platform to market.

Our Ta:RNATM platform targets and destroys cancer through a unique and powerful multi-modal approach, by selective delivery of double stranded RNA utilizing nanoparticles to harness the power of the body’s own antiviral defence response.